ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,206, issued on March 17, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Pyrazolone formyl peptide 2 receptor agonists" was invented by James A. Johnson (Pennington, N.J.), Zulan Pi (Pennington, N.J.), Nicholas R. Wurtz (Pennington, N.J.), Joanne M. Smallheer (Hernando, Fla.), Meriah Neissel Valente (Bedminister, N.J.), Ellen K. Kick (Pennington, N.J.), Charles G. Clark (Cherry Hill, N.J.), Pravin Sudhakar Shirude (Bangalore, India), Balaji Seshadri (Hosur, India) and Amit Kumar Chattopadhyay (Bangalore, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds of formula I, which are formyl peptide 2 (FP...